 | • レポートコード：MRC2-11QY02561 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗血友病因子のグローバル市場について調査・分析したレポートです。種類別（粉末、液体）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗血友病因子の競争状況、市場シェア ・世界の抗血友病因子市場：種類別市場規模 2015年-2020年（粉末、液体） ・世界の抗血友病因子市場：種類別市場規模予測 2021年-2026年（粉末、液体） ・世界の抗血友病因子市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の抗血友病因子市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の抗血友病因子市場分析：米国、カナダ ・ヨーロッパの抗血友病因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗血友病因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗血友病因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗血友病因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biogen Idec、Bayer、Octapharma、Novo Nordisk、Baxter、Genetics Institute、Wyeth Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Antihemophilic Factor Market
The global Antihemophilic Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antihemophilic Factor Scope and Market Size
Antihemophilic Factor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antihemophilic Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antihemophilic Factor market is segmented into
Powder
Liquid
Segment by Application, the Antihemophilic Factor market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Antihemophilic Factor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antihemophilic Factor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antihemophilic Factor Market Share Analysis
Antihemophilic Factor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antihemophilic Factor business, the date to enter into the Antihemophilic Factor market, Antihemophilic Factor product introduction, recent developments, etc.
The major vendors covered:
Biogen Idec
Bayer
Octapharma
Novo Nordisk
Baxter
Genetics Institute
Wyeth Pharmaceuticals
…
1 Study Coverage
1.1 Antihemophilic Factor Product Introduction
1.2 Market Segments
1.3 Key Antihemophilic Factor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antihemophilic Factor Market Size Growth Rate by Type
1.4.2 Powder
1.4.3 Liquid
1.5 Market by Application
1.5.1 Global Antihemophilic Factor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antihemophilic Factor Market Size, Estimates and Forecasts
2.1.1 Global Antihemophilic Factor Revenue 2015-2026
2.1.2 Global Antihemophilic Factor Sales 2015-2026
2.2 Global Antihemophilic Factor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antihemophilic Factor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antihemophilic Factor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antihemophilic Factor Competitor Landscape by Players
3.1 Antihemophilic Factor Sales by Manufacturers
3.1.1 Antihemophilic Factor Sales by Manufacturers (2015-2020)
3.1.2 Antihemophilic Factor Sales Market Share by Manufacturers (2015-2020)
3.2 Antihemophilic Factor Revenue by Manufacturers
3.2.1 Antihemophilic Factor Revenue by Manufacturers (2015-2020)
3.2.2 Antihemophilic Factor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antihemophilic Factor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antihemophilic Factor Revenue in 2019
3.2.5 Global Antihemophilic Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antihemophilic Factor Price by Manufacturers
3.4 Antihemophilic Factor Manufacturing Base Distribution, Product Types
3.4.1 Antihemophilic Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antihemophilic Factor Product Type
3.4.3 Date of International Manufacturers Enter into Antihemophilic Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antihemophilic Factor Market Size by Type (2015-2020)
4.1.1 Global Antihemophilic Factor Sales by Type (2015-2020)
4.1.2 Global Antihemophilic Factor Revenue by Type (2015-2020)
4.1.3 Antihemophilic Factor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antihemophilic Factor Market Size Forecast by Type (2021-2026)
4.2.1 Global Antihemophilic Factor Sales Forecast by Type (2021-2026)
4.2.2 Global Antihemophilic Factor Revenue Forecast by Type (2021-2026)
4.2.3 Antihemophilic Factor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antihemophilic Factor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antihemophilic Factor Market Size by Application (2015-2020)
5.1.1 Global Antihemophilic Factor Sales by Application (2015-2020)
5.1.2 Global Antihemophilic Factor Revenue by Application (2015-2020)
5.1.3 Antihemophilic Factor Price by Application (2015-2020)
5.2 Antihemophilic Factor Market Size Forecast by Application (2021-2026)
5.2.1 Global Antihemophilic Factor Sales Forecast by Application (2021-2026)
5.2.2 Global Antihemophilic Factor Revenue Forecast by Application (2021-2026)
5.2.3 Global Antihemophilic Factor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antihemophilic Factor by Country
6.1.1 North America Antihemophilic Factor Sales by Country
6.1.2 North America Antihemophilic Factor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antihemophilic Factor Market Facts & Figures by Type
6.3 North America Antihemophilic Factor Market Facts & Figures by Application
7 Europe
7.1 Europe Antihemophilic Factor by Country
7.1.1 Europe Antihemophilic Factor Sales by Country
7.1.2 Europe Antihemophilic Factor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antihemophilic Factor Market Facts & Figures by Type
7.3 Europe Antihemophilic Factor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antihemophilic Factor by Region
8.1.1 Asia Pacific Antihemophilic Factor Sales by Region
8.1.2 Asia Pacific Antihemophilic Factor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antihemophilic Factor Market Facts & Figures by Type
8.3 Asia Pacific Antihemophilic Factor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antihemophilic Factor by Country
9.1.1 Latin America Antihemophilic Factor Sales by Country
9.1.2 Latin America Antihemophilic Factor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antihemophilic Factor Market Facts & Figures by Type
9.3 Central & South America Antihemophilic Factor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antihemophilic Factor by Country
10.1.1 Middle East and Africa Antihemophilic Factor Sales by Country
10.1.2 Middle East and Africa Antihemophilic Factor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Antihemophilic Factor Market Facts & Figures by Type
10.3 Middle East and Africa Antihemophilic Factor Market Facts & Figures by Application
11 Company Profiles
11.1 Biogen Idec
11.1.1 Biogen Idec Corporation Information
11.1.2 Biogen Idec Description and Business Overview
11.1.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen Idec Antihemophilic Factor Products Offered
11.1.5 Biogen Idec Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Antihemophilic Factor Products Offered
11.2.5 Bayer Related Developments
11.3 Octapharma
11.3.1 Octapharma Corporation Information
11.3.2 Octapharma Description and Business Overview
11.3.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Octapharma Antihemophilic Factor Products Offered
11.3.5 Octapharma Related Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Description and Business Overview
11.4.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novo Nordisk Antihemophilic Factor Products Offered
11.4.5 Novo Nordisk Related Developments
11.5 Baxter
11.5.1 Baxter Corporation Information
11.5.2 Baxter Description and Business Overview
11.5.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Baxter Antihemophilic Factor Products Offered
11.5.5 Baxter Related Developments
11.6 Genetics Institute
11.6.1 Genetics Institute Corporation Information
11.6.2 Genetics Institute Description and Business Overview
11.6.3 Genetics Institute Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genetics Institute Antihemophilic Factor Products Offered
11.6.5 Genetics Institute Related Developments
11.7 Wyeth Pharmaceuticals
11.7.1 Wyeth Pharmaceuticals Corporation Information
11.7.2 Wyeth Pharmaceuticals Description and Business Overview
11.7.3 Wyeth Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Wyeth Pharmaceuticals Antihemophilic Factor Products Offered
11.7.5 Wyeth Pharmaceuticals Related Developments
11.1 Biogen Idec
11.1.1 Biogen Idec Corporation Information
11.1.2 Biogen Idec Description and Business Overview
11.1.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen Idec Antihemophilic Factor Products Offered
11.1.5 Biogen Idec Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antihemophilic Factor Market Estimates and Projections by Region
12.1.1 Global Antihemophilic Factor Sales Forecast by Regions 2021-2026
12.1.2 Global Antihemophilic Factor Revenue Forecast by Regions 2021-2026
12.2 North America Antihemophilic Factor Market Size Forecast (2021-2026)
12.2.1 North America: Antihemophilic Factor Sales Forecast (2021-2026)
12.2.2 North America: Antihemophilic Factor Revenue Forecast (2021-2026)
12.2.3 North America: Antihemophilic Factor Market Size Forecast by Country (2021-2026)
12.3 Europe Antihemophilic Factor Market Size Forecast (2021-2026)
12.3.1 Europe: Antihemophilic Factor Sales Forecast (2021-2026)
12.3.2 Europe: Antihemophilic Factor Revenue Forecast (2021-2026)
12.3.3 Europe: Antihemophilic Factor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antihemophilic Factor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antihemophilic Factor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antihemophilic Factor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antihemophilic Factor Market Size Forecast by Region (2021-2026)
12.5 Latin America Antihemophilic Factor Market Size Forecast (2021-2026)
12.5.1 Latin America: Antihemophilic Factor Sales Forecast (2021-2026)
12.5.2 Latin America: Antihemophilic Factor Revenue Forecast (2021-2026)
12.5.3 Latin America: Antihemophilic Factor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antihemophilic Factor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antihemophilic Factor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antihemophilic Factor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antihemophilic Factor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antihemophilic Factor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antihemophilic Factor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antihemophilic Factor Market Segments
Table 2. Ranking of Global Top Antihemophilic Factor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antihemophilic Factor Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Powder
Table 5. Major Manufacturers of Liquid
Table 6. Global Antihemophilic Factor Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Antihemophilic Factor Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Antihemophilic Factor Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Antihemophilic Factor Sales Market Share by Regions (2015-2020)
Table 10. Global Antihemophilic Factor Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antihemophilic Factor Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Antihemophilic Factor Sales Share by Manufacturers (2015-2020)
Table 13. Global Antihemophilic Factor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antihemophilic Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihemophilic Factor as of 2019)
Table 15. Antihemophilic Factor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antihemophilic Factor Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antihemophilic Factor Price (2015-2020) (US$/Ton)
Table 18. Antihemophilic Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antihemophilic Factor Product Type
Table 20. Date of International Manufacturers Enter into Antihemophilic Factor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 23. Global Antihemophilic Factor Sales Share by Type (2015-2020)
Table 24. Global Antihemophilic Factor Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antihemophilic Factor Revenue Share by Type (2015-2020)
Table 26. Antihemophilic Factor Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 28. Global Antihemophilic Factor Sales Share by Application (2015-2020)
Table 29. North America Antihemophilic Factor Sales by Country (2015-2020) (Kiloton)
Table 30. North America Antihemophilic Factor Sales Market Share by Country (2015-2020)
Table 31. North America Antihemophilic Factor Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antihemophilic Factor Revenue Market Share by Country (2015-2020)
Table 33. North America Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 34. North America Antihemophilic Factor Sales Market Share by Type (2015-2020)
Table 35. North America Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 36. North America Antihemophilic Factor Sales Market Share by Application (2015-2020)
Table 37. Europe Antihemophilic Factor Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Antihemophilic Factor Sales Market Share by Country (2015-2020)
Table 39. Europe Antihemophilic Factor Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antihemophilic Factor Revenue Market Share by Country (2015-2020)
Table 41. Europe Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Antihemophilic Factor Sales Market Share by Type (2015-2020)
Table 43. Europe Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Antihemophilic Factor Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antihemophilic Factor Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Antihemophilic Factor Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antihemophilic Factor Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antihemophilic Factor Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Antihemophilic Factor Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Antihemophilic Factor Sales Market Share by Application (2015-2020)
Table 53. Latin America Antihemophilic Factor Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Antihemophilic Factor Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antihemophilic Factor Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antihemophilic Factor Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Antihemophilic Factor Sales Market Share by Type (2015-2020)
Table 59. Latin America Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Antihemophilic Factor Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antihemophilic Factor Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Antihemophilic Factor Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antihemophilic Factor Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antihemophilic Factor Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antihemophilic Factor Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Antihemophilic Factor Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antihemophilic Factor Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Antihemophilic Factor Sales Market Share by Application (2015-2020)
Table 69. Biogen Idec Corporation Information
Table 70. Biogen Idec Description and Major Businesses
Table 71. Biogen Idec Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Biogen Idec Product
Table 73. Biogen Idec Recent Development
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. Octapharma Corporation Information
Table 80. Octapharma Description and Major Businesses
Table 81. Octapharma Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Octapharma Product
Table 83. Octapharma Recent Development
Table 84. Novo Nordisk Corporation Information
Table 85. Novo Nordisk Description and Major Businesses
Table 86. Novo Nordisk Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Novo Nordisk Product
Table 88. Novo Nordisk Recent Development
Table 89. Baxter Corporation Information
Table 90. Baxter Description and Major Businesses
Table 91. Baxter Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Baxter Product
Table 93. Baxter Recent Development
Table 94. Genetics Institute Corporation Information
Table 95. Genetics Institute Description and Major Businesses
Table 96. Genetics Institute Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Genetics Institute Product
Table 98. Genetics Institute Recent Development
Table 99. Wyeth Pharmaceuticals Corporation Information
Table 100. Wyeth Pharmaceuticals Description and Major Businesses
Table 101. Wyeth Pharmaceuticals Antihemophilic Factor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Wyeth Pharmaceuticals Product
Table 103. Wyeth Pharmaceuticals Recent Development
Table 104. Global Antihemophilic Factor Sales Forecast by Regions (2021-2026) (Kiloton)
Table 105. Global Antihemophilic Factor Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Antihemophilic Factor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Antihemophilic Factor Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Antihemophilic Factor Sales Forecast by Country (2021-2026) (Kiloton)
Table 109. North America: Antihemophilic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Antihemophilic Factor Sales Forecast by Country (2021-2026) (Kiloton)
Table 111. Europe: Antihemophilic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Antihemophilic Factor Sales Forecast by Region (2021-2026) (Kiloton)
Table 113. Asia Pacific: Antihemophilic Factor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Antihemophilic Factor Sales Forecast by Country (2021-2026) (Kiloton)
Table 115. Latin America: Antihemophilic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Antihemophilic Factor Sales Forecast by Country (2021-2026) (Kiloton)
Table 117. Middle East and Africa: Antihemophilic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Antihemophilic Factor Players
Table 122. Antihemophilic Factor Customers List
Table 123. Antihemophilic Factor Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Antihemophilic Factor Product Picture
Figure 2. Global Antihemophilic Factor Sales Market Share by Type in 2020 & 2026
Figure 3. Powder Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Antihemophilic Factor Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Antihemophilic Factor Report Years Considered
Figure 9. Global Antihemophilic Factor Market Size 2015-2026 (US$ Million)
Figure 10. Global Antihemophilic Factor Sales 2015-2026 (Kiloton)
Figure 11. Global Antihemophilic Factor Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antihemophilic Factor Sales Market Share by Region (2015-2020)
Figure 13. Global Antihemophilic Factor Sales Market Share by Region in 2019
Figure 14. Global Antihemophilic Factor Revenue Market Share by Region (2015-2020)
Figure 15. Global Antihemophilic Factor Revenue Market Share by Region in 2019
Figure 16. Global Antihemophilic Factor Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antihemophilic Factor Revenue in 2019
Figure 18. Antihemophilic Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antihemophilic Factor Sales Market Share by Type (2015-2020)
Figure 20. Global Antihemophilic Factor Sales Market Share by Type in 2019
Figure 21. Global Antihemophilic Factor Revenue Market Share by Type (2015-2020)
Figure 22. Global Antihemophilic Factor Revenue Market Share by Type in 2019
Figure 23. Global Antihemophilic Factor Market Share by Price Range (2015-2020)
Figure 24. Global Antihemophilic Factor Sales Market Share by Application (2015-2020)
Figure 25. Global Antihemophilic Factor Sales Market Share by Application in 2019
Figure 26. Global Antihemophilic Factor Revenue Market Share by Application (2015-2020)
Figure 27. Global Antihemophilic Factor Revenue Market Share by Application in 2019
Figure 28. North America Antihemophilic Factor Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Antihemophilic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Antihemophilic Factor Sales Market Share by Country in 2019
Figure 31. North America Antihemophilic Factor Revenue Market Share by Country in 2019
Figure 32. U.S. Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Antihemophilic Factor Market Share by Type in 2019
Figure 37. North America Antihemophilic Factor Market Share by Application in 2019
Figure 38. Europe Antihemophilic Factor Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Antihemophilic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Antihemophilic Factor Sales Market Share by Country in 2019
Figure 41. Europe Antihemophilic Factor Revenue Market Share by Country in 2019
Figure 42. Germany Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Antihemophilic Factor Market Share by Type in 2019
Figure 53. Europe Antihemophilic Factor Market Share by Application in 2019
Figure 54. Asia Pacific Antihemophilic Factor Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Antihemophilic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Antihemophilic Factor Sales Market Share by Region in 2019
Figure 57. Asia Pacific Antihemophilic Factor Revenue Market Share by Region in 2019
Figure 58. China Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Antihemophilic Factor Market Share by Type in 2019
Figure 81. Asia Pacific Antihemophilic Factor Market Share by Application in 2019
Figure 82. Latin America Antihemophilic Factor Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Antihemophilic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Antihemophilic Factor Sales Market Share by Country in 2019
Figure 85. Latin America Antihemophilic Factor Revenue Market Share by Country in 2019
Figure 86. Mexico Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Antihemophilic Factor Market Share by Type in 2019
Figure 93. Latin America Antihemophilic Factor Market Share by Application in 2019
Figure 94. Middle East and Africa Antihemophilic Factor Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Antihemophilic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antihemophilic Factor Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antihemophilic Factor Revenue Market Share by Country in 2019
Figure 98. Turkey Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Antihemophilic Factor Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Antihemophilic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Antihemophilic Factor Market Share by Type in 2019
Figure 105. Middle East and Africa Antihemophilic Factor Market Share by Application in 2019
Figure 106. North America Antihemophilic Factor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Antihemophilic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Antihemophilic Factor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Antihemophilic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Antihemophilic Factor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Antihemophilic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Antihemophilic Factor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Antihemophilic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Antihemophilic Factor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Antihemophilic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…- 血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 線維芽細胞成長因子2の世界市場（～2026年） Market Analysis and Insights: Global Fibroblast Growth Factor 2 Market The global Fibroblast Growth Factor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fibroblast Growth Factor 2 Scope and Market Size Fibroblast G…
- インシュリン様成長因子Iの世界市場（～2026年） Market Analysis and Insights: Global Insulin Like Growth Factor I Market The global Insulin Like Growth Factor I market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Like Growth Factor I Scope and Market Size Insuli…
- 力率補正装置の世界市場（～2026年） Power-factor correction increases the power factor of a load, improving efficiency for the distribution system to which it is attached. Linear loads with low power factor (such as induction motors) can be corrected with a passive network of capacitors or inductors. Non-linear loads, such as rectifie…